245 related articles for article (PubMed ID: 12810373)
1. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
[TBL] [Abstract][Full Text] [Related]
2. Evaluation on expression of the recombinant S gene of human hepatitis B virus in vitro and in vivo.
Yang RY; Zeng QP; Fu LC; Chen ZT
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):259-64. PubMed ID: 14599980
[TBL] [Abstract][Full Text] [Related]
3. Functional change of human peripheral blood monocyte-derived dendritic cells after recombinant adeno-associated virus type 2-mediated HBsAg gene infection.
Hu GF; Wu XB; Yu SY; Kang Y; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):696-8, 701. PubMed ID: 12865224
[TBL] [Abstract][Full Text] [Related]
4. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
5. [Transduction of dendritic cells by recombinant adeno-associated virus (rAAV) carrying hepatitis B virus antigens].
You H; Cong M; Wang P; Yan ZY; Xu Y; Lu Y; Wang BE; Jia JD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):105-7. PubMed ID: 17653305
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
7. [Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus].
Liu YZ; Zhou L; Wang Q; Ye SQ; Li HX; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):251-4. PubMed ID: 15640860
[TBL] [Abstract][Full Text] [Related]
8. [Construction and expression of recombinant adeno-associated virus vector containing HSV1-TK gene].
Ding ZX; Tan Q; Liu SZ; Liu D; Li ZQ; Peng JQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):210-5. PubMed ID: 18382054
[TBL] [Abstract][Full Text] [Related]
9. [The primary study on the anti-HBV effect of whole recombinant yeast].
Zeng Y; Cai DC; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):728-30. PubMed ID: 14697133
[TBL] [Abstract][Full Text] [Related]
10. Immune response induced by a different combined immunization of HBsAg vaccine.
Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
[TBL] [Abstract][Full Text] [Related]
11. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
[TBL] [Abstract][Full Text] [Related]
12. [Induction of specific humoral immune response in mice by recombinant mutant HBV s gene vaccine].
Ge JH; Liu HM; He J; Li YL; Yu HY; Ye Z; Zhang LZ; Hu YP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):447-9, 453. PubMed ID: 15169652
[TBL] [Abstract][Full Text] [Related]
13. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
14. [The study about immune response to Balb/c mice inoculated with hepatitis B virus DNA vaccine pCI/S2S].
He X; Zhao LS; Zhou TY; He F; Jiang N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):945-8. PubMed ID: 18095592
[TBL] [Abstract][Full Text] [Related]
15. [Recombinant adeno-associated virus carrying hepatitis B virus C gene (rAAV-HBV-C) effectively pulses dendritic cells (DC) without affecting their maturity].
Cong M; Wang P; Yan ZY; Tang SZ; Wang BE; Jia JD; Liu Y; You H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):17-9. PubMed ID: 15670484
[TBL] [Abstract][Full Text] [Related]
16. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
Kondo R; Feitelson MA; Strayer DS
Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
[TBL] [Abstract][Full Text] [Related]
17. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
[TBL] [Abstract][Full Text] [Related]
19. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
20. [Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus].
Wu Z; Wu X; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):74-8. PubMed ID: 11986753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
